TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Price-to-book ratio
3Y CAGR
+41.2%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
2.8x
Strong expansion
Streak
2 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.05 | -25.3% |
| 2024 | 1.41 | -44.3% |
| 2023 | 2.53 | +576.2% |
| 2022 | 0.37 | -44.0% |
| 2021 | 0.67 | +110.9% |
| 2020 | -6.17 | -200.2% |
| 2019 | 6.16 | - |